Established in 2008 through funding from the Bill & Melinda Gates Foundation, the SIVAC Initiative is a seven-year project implemented by the Agence de Médecine Préventive (AMP) in partnership with the International Vaccine Institute (IVI).
A Sustainable Approach to Immunization Policy Development
SIVAC aims to support the development of sustainable National Immunization Technical Advisory Groups (NITAGs) in low- and middle-income countries. The purpose of these groups is to enhance the use of evidence-based decision-making processes in the development of immunization programs and policies at national level.
Support Where It Counts
The SIVAC initiative provides support in the form of technical assistance, training, tools development, and information sharing. These activities fall into two core areas:
- Support for NITAG establishment, development, and strengthening. SIVAC directly operates in about 15 countries in Africa, Asia, Europe, and the Middle East.
- Knowledge sharing through the NITAG Resource Center– a multilingual website that offers information, tools, and short learning modules – the development of articles and tools, and the organization of regional technical workshops.
Teaming Up for Better Health
To achieve its objectives and to increase efficiency, SIVAC develops partnerships and synergies with governments, research institutions, and international health organizations.